ESSKA SHOES LIMITED

Company number 05825485 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Based on the financial data provided for Esska Shoes Limited, here is my comprehensive financial health assessment.

1. Financial Health Score: B

Explanation: Esska Shoes Limited is a financially stable and profitable company with a strong cash position. The company has demonstrated impressive growth and resilience, moving from a negative net worth in 2015 to a healthy, positive position today. The score is not an 'A' due to a significant increase in current liabilities in the most recent year and a pattern of high dividend payouts which have reduced retained earnings. While the company is in good shape, these factors introduce a degree of vulnerability that warrants attention.

2. Key Vital Signs

Here are the critical metrics and what they indicate about the company's health.

Vital Sign 2024 2023 2022 Trend Interpretation
Net Assets £819,213 £857,416 £1,168,383 📉 (Declining) The company's net worth is falling year-over-year, a symptom of outflows exceeding profits.
Cash at Bank £995,146 £1,004,537 £1,154,964 📉 (Declining) The company's "blood supply" is healthy but decreasing. It still has an excellent cash buffer.
Profit & Loss Reserve £819,203 £857,406 £1,168,373 📉 (Declining) The cumulative retained profit is shrinking, indicating profits are being distributed rather than retained for growth.
Current Liabilities £503,209 £312,986 £413,137 📈 (Spiking) A sharp increase in short-term debts, which is a key symptom of financial strain.
Net Current Assets (Working Capital) £788,235 £817,052 N/A 📉 (Declining) The company's ability to meet short-term obligations is slightly weaker, but still very strong.
Profit for the Year £357,797 £499,033 N/A 📉 (Declining) Profitability is still robust, but the year-on-year decline suggests a potential loss of momentum.
Dividends Paid £396,000 £810,000 N/A 📉 (Varying) High dividend payments are the primary cause of the decline in net assets and cash.

Additional Context: - Long-term Growth: The company has transformed from a negative net worth of -£4,609 in 2015 to assets of £1.29M, demonstrating exceptional long-term health and growth. - Liquidity: The company has a very high cash-to-liabilities ratio. Even with the spike in liabilities, cash (£995k) covers them nearly twice over. This is a sign of a very strong "immune system."

3. Diagnosis: The "Profitable Patient with a Dividend Habit"

The overall financial condition of Esska Shoes Limited can be diagnosed as "Stable but Vulnerable to Self-Inflicted Wounds."

The company has a strong underlying constitution (high profitability, excellent cash reserves, low fixed asset base). However, the financial statements reveal a clear pattern: the company is generating strong profits but is simultaneously paying out a very high proportion of these profits as dividends to its shareholders.

In 2024, the company paid out more in dividends (£396k) than it made in profit (£357k) , effectively depleting its retained earnings and cash reserves. While this is a strategic choice for the directors/shareholders, it is the primary symptom of the decline in net assets. The sharp increase in "Amounts owed to group undertakings" (from £0 to £225,000) is a related symptom, suggesting the company may be using intercompany debt to finance its operations or dividend payments rather than relying solely on its own cash flow.

The company is a "healthy athlete" who is choosing to run a marathon while also giving away a significant amount of their energy reserves. They will likely finish the race, but they are making it harder on themselves than necessary.

4. Recommendations: A Prescription for Enhanced Financial Wellness

To improve its financial wellness and ensure long-term resilience, Esska Shoes Limited should consider the following:

  1. Re-evaluate the Dividend Policy: The primary recommendation is to align dividend payouts more closely with sustainable profits. Paying out more than 100% of net profit, as seen in 2024, is a red flag. A more conservative policy (e.g., 50-70% of net profit) would allow the company to rebuild its retained earnings and cash buffer, providing a stronger defense against future economic downturns or unexpected expenses.

  2. Invest in Growth: Instead of distributing all excess cash, the company could reinvest a portion into the business. The small increase in fixed assets (£10k in 2024) suggests a lack of capital investment. Options include:

    • Marketing and Brand Building: To combat the slight decline in profitability.
    • Inventory Management: The stock level has jumped from £52k to £232k. An analysis of stock turnover is needed. This could be a sign of healthy growth or a sign of slow-moving stock tying up cash.
    • Technology & Efficiency: Investing in systems to improve margins and reduce costs.
  3. Monitor the Intercompany Loan: The new £225,000 loan to a group undertaking needs to be actively managed. Ensure the terms are clear, formalized, and that the company is receiving a fair market rate of interest on this loan. It should not become a hidden drain on the company's cash.

  4. Perform a "Stress Test": The directors should model what would happen to the business if sales dropped by 20% or if a major customer delayed payment. Given the high dividend payout, the company's buffer is thinner than it appears. A stress test would quantify the risk and inform the dividend decision.


Perspective: Financial Health Diagnostician · Model: deepseek/deepseek-v4-flash · Generated 28 August 2026